Back to search

Article

S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition

2023-09-23

Abstract excerpt

<h4>ABSTRACT</h4> It remains elusive why some triple-negative breast cancer (TNBC) patients respond poorly to existing therapies while others respond well. Our retrospective analysis of historical gene expression datasets reveals that increased expression of immunosuppressive cytokine S100A8/A9 in early-stage tumors is robustly associated with subsequent disease progression in TNBC. Although it has recently gaine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6f7a2e6-3153-56c8-996d-e1f99414a6c4
DOI
10.1101/2023.09.21.558870
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibitionDOI 10.1101/2023.09.21.558870
Select a neighboring publication to make it the new centre.